• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

CTA Launches First-Ever Ansi-Accredited Standard for AI in Healthcare

Share:

February 27, 2020

Highlights on this story:
  • The Consumer Technology Association (CTA) announces the first-ever ANSI-accredited standard for the use of artificial intelligence in healthcare, developed by more than 50 organizations from tech giants to healthcare leaders.
  • CTA convened 52 organizations – including IBM, Philips, BlackBerry, Doctor on Demand, Humetrix, American Medical Association, and AdvaMed – to develop this standard that provides a foundation to better understand AI technologies and common terminology so consumers, tech companies and care providers can better communicate, develop and use AI-based healthcare technologies.

More than 50 organizations – from major tech giants to startups and healthcare industry leaders – convened by the Consumer Technology Association (CTA) have developed the first-ever ANSI-accredited standard for the use of artificial intelligence in healthcare. The standard is part of CTA’s new initiative that will set a foundation for implementing medical and healthcare solutions built on AI.

Growing Importance of AI in Healthcare

As the healthcare system deals with clinician shortages, an aging population and the persistence of chronic diseases in the US, technologically driven solutions, such as AI, will increasingly be used to meet clinician and patient needs, the group notes. Today, AI-related terms are used in different ways including telehealth and remote patient monitoring, leading to confusion for healthcare organizations

“AI will play a major role in driving efficiency in healthcare and will support clinicians in making more precise diagnosis, offer personalized treatment and better guidance towards improved outcomes,” said Pat Baird, regulatory head of global software standards at Philips and co-chair of the working group. “This implies that AI will be used for decision support and decision making, which stresses the need for professionals to be able to take ownership, apply judgment and empathy. Transparency and a common language will be key to enable the proper and safe functioning of AI.”

Establishing a Standardized Framework for Understanding AI in Healthcare

To address this problem, CTA announced the working group with 30 members less than a year ago, which now includes a wide range of decisionmakers from 52 organizations and member companies to develop a standard built on consensus. The standard – 11 definitions and characteristics – provides a framework for better understanding AI technologies and common terminology so consumers, tech companies and care providers can better communicate, develop and use AI-based healthcare technologies.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

A broader AI committee at CTA also published an ANSI-accredited standard that addresses the pervasiveness of AI-enabled technology across the entire consumer technology industry. The standard defines over 30 terms including machine learning, model bias, artificial neural network and trustworthiness.

Among the definitions, the standard includes highly debated terms such as “assistive intelligence,” which the group defined as a category of AI software that “informs” or “drives” diagnosis or clinical management of a patient, however, the healthcare provider makes the ultimate decisions before clinical action is taken. Other definitions include terms like de-identified data, synthetic data, remote patient monitoring, and patient decision support system.

Source: Hit Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • JAMA Study Warns Telemedicine Not Suitable for 38% of Patients Over 65JAMA Study Warns Telemedicine Not Suitable for 38% of Patients Over 65
  • Boston Scientific Announces Agreement To Acquire Lumenis LTD. Surgical Business From Baring Private Equity AsiaBoston Scientific Announces Agreement To Acquire Lumenis LTD. Surgical Business From Baring Private Equity Asia
  • AristaMD Raises $18M to Expand eConsults Platform to Improve Patient OutcomesAristaMD Raises $18M to Expand eConsults Platform to Improve Patient Outcomes
  • Microsoft, Astrazeneca Launches AI Factory For Health Accelerator In EuropeMicrosoft, Astrazeneca Launches AI Factory For Health Accelerator In Europe
  • HeartBeam Forms Strategic Alliance with SamsungHeartBeam Forms Strategic Alliance with Samsung
  • Helium Health Closes $10M Series A, Led By Dubai Venture Capital FundHelium Health Closes $10M Series A, Led By Dubai Venture Capital Fund
  • Finding a solution for AI in HealthcareFinding a solution for AI in Healthcare
  • DionyMed Announces Close of Acquisition with Innovative Industrial Properties for MMAC’s 1.83 acre Los Angeles CampusDionyMed Announces Close of Acquisition with Innovative Industrial Properties for MMAC’s 1.83 acre Los Angeles Campus

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications